Security
VolitionRx Limited · VNRX
VNRXNYSE_AMERICANCommon stockCurrentCIK 93314Updated Oct 28, 2026
Name history
VOLITIONRX LTD · through Oct 27, 2026STANDARD CAPITAL CORP · through Sep 29, 2011
VNRX price & chart
Loading TradingView…
AMEX:VNRX on TradingView ↗About the company
We are a smaller reporting company and a non-accelerated filer, and we cannot be certain if the reduced disclosure requirements applicable to our filing status, as well as the exemption from the requirement to provide an auditor’s attestation report regarding the effectiveness of our internal controls, will make our common stock less attractive to investors.
In the news
VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash ↗
VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash ↗
Recent filings
Entry into a Material Definitive Agreement · Other Events
Items 1.01, 8.01, 9.01
Unregistered Sales of Equity Securities
Items 3.02
SCHEDULE 13D/A - filed by Lagoda Investment Management, L.P. regarding VOLITIONRX LTD
Unregistered Sales of Equity Securities
Items 3.02
Other Events
Items 8.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 6,448,885Source | 12,680,255Source | 8,300,986Source | 8,704,790Source | 13,068,037Source | 9,036,483Source | 8,520,057Source | 19,434,900Source | 6,901,227Source | 9,399,523Source | 27,950,498Source | 18,295,054Source |
| Property, Plant and Equipment, NetUSD | 4,243,486Source | 4,908,148Source | 3,564,114Source | 4,500,065Source | 4,878,417Source | 3,771,181Source | 4,348,316Source | 5,180,551Source | 4,027,849Source | 4,429,152Source | 5,523,013Source | 5,393,012Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | — | — | — | — | — | 215,133Source | — | — | 23,886Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 200,000Source | — | 2,800,000Source | 2,300,000Source | — | — | 2,600,000Source | 11,772,163Source | 1,117,028Source | 3,264,429Source | 20,729,983Source | 10,867,050Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 309,085Source | 312,611Source | 277,355Source | 189,597Source | 166,262Source | 252,242Source | 187,830Source | 133,500Source | 317,808Source | 110,574Source | 242,617Source | 72,609Source |
| Assets, CurrentUSD | 1,332,077Source | 6,800,941Source | 4,092,944Source | 3,263,307Source | 7,345,082Source | 4,516,391Source | 3,294,002Source | 13,470,053Source | 2,060,925Source | 4,056,808Source | 21,854,095Source | 12,172,145Source |
| Operating Lease, Right-of-Use AssetUSD | 572,289Source | 635,857Source | 338,795Source | 635,041Source | 512,317Source | 430,010Source | 560,610Source | 569,163Source | 495,749Source | 599,816Source | 549,504Source | 619,392Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 42,398,447Source | 35,320,545Source | 41,840,346Source | 41,803,112Source | 35,965,648Source | 42,396,412Source | 37,546,732Source | 36,054,951Source | 42,494,038Source | 35,507,259Source | 36,662,720Source | 21,422,016Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 109,620Source | 92,393Source | 12,044Source | 103,982Source | 82,928Source | 7,931Source | 100,747Source | 82,109Source | 125,780Source | 96,098Source | 81,898Source | 57,873Source |
| Additional Paid in CapitalUSD | 212,307,711Source | 202,014,277Source | 235,263,755Source | 209,777,146Source | 195,755,863Source | 227,744,249Source | 206,961,962Source | 194,997,353Source | 218,824,268Source | 204,154,994Source | 194,448,414Source | 164,397,468Source |
| Retained Earnings (Accumulated Deficit)USD | -246,630,538Source | -223,750,970Source | -267,352,291Source | -241,252,180Source | -217,929,441Source | -259,566,144Source | -234,968,102Source | -210,943,895Source | -252,901,370Source | -229,544,343Source | -202,576,507Source | -167,257,429Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -421,946Source | 140,272Source | -88,451Source | -444,294Source | 282,252Source | -160,764Source | 131,702Source | 258,966Source | -295,071Source | 385,631Source | 243,940Source | 227,097Source |
| Stockholders' Equity Attributable to ParentUSD | -34,635,153Source | -21,504,028Source | -32,164,943Source | -31,815,346Source | -21,808,398Source | -31,974,728Source | -27,773,691Source | -15,605,467Source | -34,246,393Source | -24,907,620Source | -7,802,255Source | -3,126,962Source |
| Liabilities and EquityUSD | 6,448,885Source | 12,680,255Source | 8,300,986Source | 8,704,790Source | 13,068,037Source | 9,036,483Source | 8,520,057Source | 19,434,900Source | 6,901,227Source | 9,399,523Source | 27,950,498Source | 18,295,054Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 11,422,027Source | 30,279,477Source | 13,492,636Source | 9,240,878Source | 30,975,614Source | 13,567,421Source | 8,273,099Source | 31,492,372Source | 12,230,753Source | 7,790,747Source | 31,837,077Source | 17,386,087Source |
| Operating Lease, Liability, CurrentUSD | 254,644Source | 219,060Source | 204,724Source | 252,013Source | 190,099Source | 250,117Source | 224,690Source | 201,047Source | 250,336Source | 221,755Source | 199,323Source | 245,163Source |
| Accounts Payable, CurrentUSD | 3,114,430Source | 2,485,077Source | 3,564,762Source | 2,351,261Source | 3,348,322Source | 3,718,795Source | 3,011,897Source | 3,527,673Source | 2,918,768Source | 2,766,178Source | 3,211,287Source | 3,043,008Source |
| Operating Lease, Liability, NoncurrentUSD | 351,211Source | 448,045Source | 157,478Source | 417,015Source | 350,810Source | 208,660Source | 369,342Source | 396,376Source | 276,558Source | 410,686Source | 378,054Source | 400,091Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -1,314,409Source | -1,136,262Source | -1,374,417Source | -1,282,976Source | -1,089,213Source | -1,385,201Source | -1,252,984Source | -1,014,584Source | -1,346,418Source | -1,200,116Source | -909,967Source | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 4,585,137Source | 3,480,207Source | 2,670,128Source | 4,389,312Source | 3,227,595Source | 3,870,169Source | 3,698,868Source | 3,305,316Source | 4,211,828Source | 3,476,903Source | 3,928,761Source | 2,872,247Source |
| Deferred Revenue, CurrentUSD | 354,000Source | 22,893,400Source | 177,582Source | 122,441Source | 22,938,400Source | 353,846Source | 230,000Source | 23,000,000Source | 353,846Source | 230,000Source | 23,000,000Source | 10,000,000Source |
| Deferred Revenue, NoncurrentUSD | 22,026,769Source | — | 21,225,421Source | 22,663,400Source | — | 21,225,421Source | 22,663,400Source | — | 21,938,462Source | — | — | — |
| Long-term Debt, Excluding Current Maturities | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Long-term Debt, Current MaturitiesUSD | 913,582Source | 965,021Source | 1,070,020Source | 1,017,348Source | 1,043,142Source | 940,258Source | 862,475Source | 1,149,944Source | 890,571Source | 860,223Source | 1,207,007Source | 1,066,700Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 5,565,751Source | 3,837,950Source | 5,981,815Source | 5,771,375Source | 3,865,357Source | 6,351,763Source | 5,532,382Source | 3,372,568Source | 5,818,354Source | 3,952,846Source | 3,624,860Source | 2,779,240Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -5,409,791Source | -5,868,578Source | -7,315,263Source | -6,314,070Source | -6,703,557Source | -5,476,627Source | -23,503,329Source | -27,257,985Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 224,981Source | 451,374Source | 1,739,711Source | 1,268,543Source | 2,289,545Source | 0Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -65,566Source | 77,256Source | 207,234Source | -132,045Source | -169,666Source | -72,609Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -5,280,132Source | -4,298,018Source | -19,683,334Source | -25,893,624Source | -18,062,999Source | -15,277,742Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -9,214Source | -1,808Source | -89,558Source | -573,852Source | -1,083,749Source | -1,570,182Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 9,214Source | 1,808Source | 89,558Source | 277,499Source | 1,083,749Source | 1,570,182Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 15,706Source | 24,411Source | 210,034Source | 139,939Source | 203,878Source | — |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | 0Source | 31,772Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 7,616,176Source | 3,667,080Source | 17,092,858Source | 8,657,254Source | 28,982,685Source | 6,938,032Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 246,186Source | 251,759Source | 877,550Source | 1,087,550Source | 981,291Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 1,985,789Source | -664,087Source | -2,147,401Source | -17,465,554Source | 9,862,933Source | -9,714,263Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 199,407Source | 5,414,146Source | 2,790,994Source | 2,255,996Source | 3,102,817Source | 2,600,342Source | 1,117,028Source | 3,264,429Source | 20,729,983Source | 10,867,050Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 125,842Source | 96,669Source | 280,718Source | 340,362Source | 221,622Source | 173,087Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -341,041Source | -31,341Source | 532,633Source | 344,668Source | 26,996Source | 195,629Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 1,077,417Source | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 6,172Source | 6,017Source | 24,012Source | 0Source | 84,910Source | 75,558Source |
| DepreciationUSD | — | — | — | — | — | — | 201,199Source | 246,248Source | 1,000,000Source | 1,100,000Source | 1,080,475Source | 865,262Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | 304,443Source | 0Source | -1,374,076Source | 418,681Source | 98,642Source | 0Source | 128,729Source | 28,763Source | 240,311Source | — |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | 0Source | -1,195Source | 341Source | 330Source | — | — | 1,829Source | -34,731Source | -15,843Source | — |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | — | — | -34,731Source | — | — |
| General and Administrative ExpenseUSD | — | — | 2,483,793Source | 1,815,863Source | 2,205,471Source | 2,940,754Source | 2,629,826Source | 2,243,362Source | 9,463,581Source | 8,487,562Source | 10,368,314Source | 10,937,686Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,378,358Source | -5,821,529Source | -7,326,047Source | -6,284,078Source | -6,664,774Source | -5,423,759Source | -23,357,027Source | -27,257,985Source | -35,677,074Source | -30,598,469Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | -47,049Source | 10,784Source | -29,992Source | -38,783Source | -52,868Source | — | -290,149Source | 357,996Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -5,821,529Source | — | — | — | — | — | -26,967,836Source | — | — |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | 310,621Source | — |
| Operating ExpensesUSD | — | — | 5,728,267Source | 6,343,229Source | 4,554,640Source | 6,704,495Source | 6,333,928Source | 5,768,105Source | 23,465,955Source | 28,258,481Source | 36,762,997Source | 32,086,464Source |
| Other Nonoperating Income (Expense)USD | — | — | -308,801Source | 129Source | -3,159,280Source | -16,263Source | -1,354,705Source | 45,093Source | -1,764,758Source | -233,015Source | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 5,173,805Source | 2,384,654Source | 11,170,410Source | 8,592,177Source | 28,388,036Source | 6,736,444Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | 962,723Source | 1,570,176Source | 1,980,178Source | 1,368,502Source | 1,854,877Source | — |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| InterestExpenseNonoperating | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 627,277Source | 474,522Source | 398,657Source | 406,688Source | 985,076Source | 246,385Source | 1,727,384Source | 1,233,511Source | 775,302Source | 306,392Source |
| Operating Income (Loss)USD | — | — | -5,100,990Source | -5,868,707Source | -4,155,983Source | -6,297,807Source | -5,348,852Source | -5,521,720Source | -21,738,571Source | -27,024,970Source | -35,987,695Source | -31,780,072Source |
| Other Nonoperating Income (Expense)USD | — | — | -308,801Source | 129Source | -3,159,280Source | -16,263Source | -1,354,705Source | 45,093Source | -1,764,758Source | -233,015Source | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | -47,049Source | 10,784Source | -29,992Source | -38,783Source | -52,868Source | — | -290,149Source | 357,996Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,378,358Source | -5,821,529Source | -7,326,047Source | -6,284,078Source | -6,664,774Source | -5,423,759Source | -23,357,027Source | -27,257,985Source | -35,677,074Source | -30,598,469Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.05Source | -0.07Source | -0.85Source | -1.22Source | -0.97Source | -1.12Source | — | -0.31Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 108,213,068Source | 87,886,012Source | 9,154,815Source | 5,132,705Source | 6,882,744Source | 4,826,803Source | 106,832,140Source | 86,531,172Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 6,172Source | 6,017Source | 24,012Source | 0Source | 84,910Source | 75,558Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 19Source | — | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 207,371Source | 251,941Source | 983,706Source | 1,113,184Source | 1,152,534Source | 936,084Source |
| General and Administrative ExpenseUSD | — | — | 2,483,793Source | 1,815,863Source | 2,205,471Source | 2,940,754Source | 2,629,826Source | 2,243,362Source | 9,463,581Source | 8,487,562Source | 10,368,314Source | 10,937,686Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source |
| Interest Income, OtherUSD | — | — | 160Source | 530Source | 163Source | 160Source | 16Source | 158Source | 600Source | 9,947Source | 93,324Source | 125,265Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -5,821,529Source | — | — | — | — | — | -26,967,836Source | — | — |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | 310,621Source | — |
| Operating ExpensesUSD | — | — | 5,728,267Source | 6,343,229Source | 4,554,640Source | 6,704,495Source | 6,333,928Source | 5,768,105Source | 23,465,955Source | 28,258,481Source | 36,762,997Source | 32,086,464Source |
| Other IncomeUSD | — | — | — | — | — | — | — | — | — | — | — | 1,181,603Source |
| Research and Development ExpenseUSD | — | — | 2,285,907Source | 3,473,782Source | 1,800,656Source | 2,720,207Source | 2,852,251Source | 2,607,444Source | 10,081,299Source | 14,406,486Source | 19,551,523Source | 14,572,532Source |
| Selling and Marketing ExpenseUSD | — | — | 958,567Source | 1,053,584Source | 548,513Source | 1,043,534Source | 851,851Source | 917,299Source | 3,921,075Source | 5,364,433Source | 6,843,160Source | 6,576,246Source |
| Interest Expense (non-operating) | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
Offerings
Registration 333-298627
Registration 333-297402
Registration 333-293314
Registration 333-286401
Filing attachments
vnrx_ex991.htm · 8-K · 2026-10-27
EXHIBIT 99.1 VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash Reduces outstanding principal to only $0.7 million on the $2.4 million note and brings total debt reduction across both notes to over $5.0 million since June 30, 2026. Secures agreement pausing conversion rights until January 2027 (unless closing share price equals or exceeds $0.275) and deferring remaining monthly repayments for 2026. HENDERSON, Nev., Oct. 27, 2026 /PRNewswire/ -- VolitionR…
Read attachment ↗vnrx_ex991.htm · 8-K · 2026-09-14
EX-99.1 2 vnrx_ex991.htm PRESS RELEASE vnrx_ex991.htm EXHIBIT 99.1 VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 Reduces Equity Overhang Henderson, Nevada, September 14, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, today announces the full pre-payment in cash of the outstanding balance on its senior secured convertible promissory note, dated …
Read attachment ↗vnrx_ex107.htm · S-3 · 2026-08-28
EXHIBIT 107 Calculation of Filing Fee Tables Form S-3 (Form Type) VolitionRx Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Fee Proposed Calculation Maximum …
Read attachment ↗vnrx_ex107.htm · S-8 · 2026-08-21
EXHIBIT 107 Calculation of Filing Fee Table Form S-8 (Form Type) VolitionRx Limited (Exact Name of Registrant as Specified in its Charter) Newly Registered Securities Security Type Security Class Title Fee Calculation Amount Registered(1) Proposed Maximum Fee Rate Amount of Registration Fee …
Read attachment ↗vnrx_ex43.htm · S-8 · 2026-08-21
EXHIBIT 4.3 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF VOLITIONRX LIMITED _______________ VolitionRx Limited, a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify: 1. The original Certificate of Incorporation was filed with the Secretary of State on September 24, 1998, under the name Standard Capital Corporation, and amended and restated as filed with the Secretary of State on September 30…
Read attachment ↗vnrx_ex107.htm · 10-Q · 2026-08-13
EXHIBIT 10.7 NOTICE OF STOCK OPTION GRANT VOLITIONRX LIMITED 2026 STOCK INCENTIVE PLAN Unless otherwise defined herein, the terms defined in the VolitionRx Limited (the “Company”) 2026 Stock Incentive Plan (the “Plan”) shall have the same meanings in this Notice of Stock Option Grant (the “Notice of Grant”) and the attached Stock Option Agreement (the “Option Agreement”). You have been granted an Option to purchase shares of Common Stock of the Company under the Plan subject to the terms and…
Read attachment ↗